| Rachel Cockerham, | |
|
1355 Old York Road, Suite 101, Abington, PA 19001 | |
| (215) 886-2433 | |
| Not Available |
| Full Name | Rachel Cockerham |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Lactation Consultant |
| Location | 1355 Old York Road, Abington, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376064394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WL0100X | Registered Nurse - Lactation Consultant | L-124871 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Cockerham, 1355 Old York Rd Ste 101, Abington, PA 19001-3413 Ph: (215) 886-2433 | Rachel Cockerham, 1355 Old York Road, Suite 101, Abington, PA 19001 Ph: (215) 886-2433 |
News Archive
The Association for Chemoreception Sciences (AChemS), a US-based scientific organization, is holding its 32nd annual meeting. About 700 scientists are gathering to present new information on the role of smell and taste in disease, nutrition and social interactions in humans as well as animals. Smell and taste play essential roles in our daily lives. These chemical senses serve as important warning systems, alerting us to the presence of potentially harmful situations or substances, including gas leaks, smoke, and spoiled food.
Dr. Spencer Greene wants to make sure the standard treatment for copperhead snake bites, the most common venomous snake in greater Houston and southeast Texas, works, and if it doesn't, he wants to stop its use.
new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center along with colleagues at the Cleveland Clinic, the Veterans Administration Boston Healthcare and the National Cancer Institute, may prove to be a promising new tool in the diagnosis of prostate cancer.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.
› Verified 1 days ago
Esther Haejin Cheon, Registered Nurse Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Gabrielle Dalton, CRNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 1021 Old York Rd Ste 301, Abington, PA 19001 Phone: 215-254-6000 Fax: 215-754-1705 | |
Miss Caroline Kate Darlington, MSN, WHNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Michelle Potts, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1400 Old York Rd, Abington, PA 19001 Phone: 215-481-6106 | |
Mrs. Brianna Sarah Jackson, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1355 Old York Rd, Abington, PA 19001 Phone: 215-886-2433 | |
Christine Ilik, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1400 Old York Rd Ste E, Abington, PA 19001 Phone: 215-481-6106 | |
Moira K Baker, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 |